---
title: "Tilray Brands, Inc. (TLRY.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TLRY.US.md"
symbol: "TLRY.US"
name: "Tilray Brands, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-19T20:25:56.892Z"
locales:
  - [en](https://longbridge.com/en/quote/TLRY.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TLRY.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TLRY.US.md)
---

# Tilray Brands, Inc. (TLRY.US)

## Company Overview

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.tilray.com](https://www.tilray.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:12.000Z

**Overall: C (0.59)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 76 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 3.82% |  |
| Net Profit YoY | -42.18% |  |
| P/B Ratio | 0.39 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 603722074.34 |  |
| Revenue | 858275000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -62.73% | E |
| Profit Margin | -156.67% | E |
| Gross Margin | 26.58% | C |
| Revenue YoY | 3.82% | C |
| Net Profit YoY | -42.18% | D |
| Total Assets YoY | -39.04% | E |
| Net Assets YoY | -43.54% | E |
| Cash Flow Margin | 3.32% | D |
| OCF YoY | 3.82% | C |
| Turnover | 0.31 | D |
| Gearing Ratio | 26.47% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Tilray Brands, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "3.82%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-42.18%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.39",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "603722074.34",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "858275000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-62.73%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-156.67%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "26.58%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "3.82%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-42.18%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-39.04%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-43.54%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "3.32%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "3.82%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.31",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "26.47%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.45 | 84/190 | - | - | - |
| PB | 0.39 | 15/190 | 0.88 | 0.56 | 0.40 |
| PS (TTM) | 0.70 | 25/190 | 1.62 | 1.06 | 0.77 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-16T04:00:00.000Z

Total Analysts: **10**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 30% |
| Hold | 6 | 60% |
| Underweight | 1 | 10% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.21 |
| Highest Target | 24.00 |
| Lowest Target | 6.50 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TLRY.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TLRY.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TLRY.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TLRY.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**